PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 77 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $33,000 | -94.4% | 17,470 | -91.1% | 0.00% | -100.0% |
| Q1 2022 | $593,000 | -38.2% | 195,830 | -22.9% | 0.01% | -44.4% |
| Q4 2021 | $960,000 | -57.0% | 254,036 | -41.2% | 0.01% | -67.9% |
| Q3 2021 | $2,235,000 | +1271.2% | 432,289 | +913.7% | 0.03% | +1300.0% |
| Q2 2021 | $163,000 | +101.2% | 42,643 | +91.2% | 0.00% | +100.0% |
| Q4 2019 | $81,000 | +350.0% | 22,308 | +477.9% | 0.00% | – |
| Q2 2019 | $18,000 | +260.0% | 3,860 | +157.3% | 0.00% | – |
| Q1 2019 | $5,000 | -84.4% | 1,500 | -87.7% | 0.00% | -100.0% |
| Q4 2018 | $32,000 | -80.0% | 12,159 | -61.4% | 0.00% | -75.0% |
| Q2 2018 | $160,000 | -43.3% | 31,474 | -24.0% | 0.01% | -52.9% |
| Q1 2018 | $282,000 | +213.3% | 41,391 | +245.6% | 0.02% | +240.0% |
| Q4 2017 | $90,000 | – | 11,978 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |